Scotland has approved its first CLDN18.2-targeted therapy for advanced gastric and GEJ cancer, expanding options for patients ...
A nonprofit organization that offers recovery services will host its 21st annual luncheon with proceeds to benefit the organization’s alcohol and drug treatment programs, slated for next month at Palm ...
Sydney Towle, 26, has documented her journey with rare, aggressive bile duct cancer since she was diagnosed in 2023 ...
Interest in treating autism with leucovorin is based mainly on the presence of autoantibodies to the FOLR1 protein in autistic persons and the implication that these antibodies impair folate transport ...
Differentiating palliative care from hospice is crucial; palliative care focuses on holistic treatment, while hospice ...
The new generic drug has been approved for treatment of bovine respiratory disease and associated pyrexia in beef and ...
A new bill in the West Virginia Legislature would establish a mandatory drug-screening program for anyone applying to become ...
A new preclinical study from researchers at The University of Texas MD Anderson Cancer Center, published in Nature ...
Researchers from Leiden University Medical Center (LUMC) and the Leiden-based biotech company Ncardia have joined forces to ...
Jaguar has received the initial $16M payment related to the company's recently executed US out-license agreement for ...
Lexicon Pharmaceuticals, Inc. is downgraded to Hold due to repeated FDA rejections of ZYNQUISTA for T1D and catalysts. Read more on LXRX stock here.
Parents of autistic children are clamoring for a prescription vitamin promoted by federal health officials. But there's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback